Bullous Pemphigoid IgG Induces BP180 Internalization via a Macropinocytic Pathway  by Hiroyasu, Sho et al.
The American Journal of Pathology, Vol. 182, No. 3, March 2013ajp.amjpathol.orgIMMUNOPATHOLOGY AND INFECTIOUS DISEASES
Bullous Pemphigoid IgG Induces BP180 Internalization
via a Macropinocytic Pathway
Sho Hiroyasu,* Toshiyuki Ozawa,y Hiromi Kobayashi,* Masamitsu Ishii,* Yumi Aoyama,z Yasuo Kitajima,x Takashi Hashimoto,{
Jonathan C.R. Jones,k and Daisuke Tsuruta*{From the Departments of Dermatology* and Plastic and Reconstructive Surgery,y Osaka City University Graduate School of Medicine, Osaka, Japan; the
Department of Dermatology,z Okayama University Graduate School of Medicine, Okayama, Japan; the Division of Dermatology,x Kizawa Memorial Hospital,
Gifu, Japan; the Department of Dermatology,{ Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Fukuoka,
Japan; and the Department of Cell and Molecular Biology,k Northwestern University the Feinberg School of Medicine, Chicago, IllinoisAccepted for publicationC
P
hNovember 14, 2012.
Address correspondence to
Daisuke Tsuruta, M.D., Ph.D.,
Department of Dermatology,
Osaka City University Graduate
School of Medicine, 1-4-3
Asahimachi, Abeno-ku, Osaka
545-8585, Japan. E-mail:
dtsuruta@med.osaka-cu.ac.jp.opyright ª 2013 American Society for Inve
ublished by Elsevier Inc. All rights reserved
ttp://dx.doi.org/10.1016/j.ajpath.2012.11.029Bullous pemphigoid (BP) is an autoimmune blistering skin disease induced by pathogenic autoantibodies
against a type II transmembrane protein (BP180, collagen type XVII, or BPAG2). In animal models,
BP180 autoantibody-antigen interaction appears insufﬁcient to develop blisters, but involvement of
complement and neutrophils is required. However, cultured keratinocytes treated with BP-IgG exhibit
a reduction in the adhesive strength and a loss of expression of BP180, suggesting that the autoanti-
bodies directly affect epidermal celleextracellular matrix integrity. In this study, we explored the
consequences of two distinct epithelial cells treated with BP-IgG, particularly the fate of BP180. First, we
followed the distribution of green ﬂuorescent proteinetagged BP180 in an epithelial cell line, 804G, and
normal human epidermal keratinocytes after autoantibody clustering. After BP-IgG treatment, the
adhesive strength of the cells to their substrate was decreased, and BP180 was internalized in both cell
types, together with the early endosomal antigen-1. By using various endocytosis inhibitors and a ﬂuid-
uptake assay, we demonstrated that BP-IgGeinduced BP180 internalization is mediated via a macro-
pinocytic pathway. Moreover, a macropinocytosis inhibitor rescued a BP-IgGeinduced reduction in the
adhesive strength of the cells from their substrate. The results of this study suggest that BP180 inter-
nalization induced by BP-IgG plays an important role in the initiation of disease pathogenesis.
(Am J Pathol 2013, 182: 828e840; http://dx.doi.org/10.1016/j.ajpath.2012.11.029)Supported by The Osaka Medical Research Foundation for Intractable
Diseases grant 15-23 (S.H.), the Japanese Dermatological Association
Shiseido Award 23-13, the Ministry of Education, Culture, Sports, Science
and Technology of Japan Grants-in-Aid for Science Research and Strategic
Research Basis Formation Supporting Project J112640081 (D.T.), and NIH
grant R01 AR054184 (J.C.R.J.).Bullous pemphigoid (BP) is one of the most common
autoimmune blistering diseases and is characterized by tense
inﬂammatory subepidermal bullae caused by anti-basement
membrane zone autoantibodies.1,2 BP autoantigens are two
major hemidesmosomal components, BP180/type XVII
collagen/BPAG2 and BP230/BPAG1e.3e6
Whether anti-BP230 autoantibodies directly contribute
to BP pathogenesis is controversial.7,8 In contrast, se-
veral studies using experimental animal models have
suggested that IgG anti-BP180 antibodies contribute to
BP blister formation. Speciﬁcally, passive transfer of
rabbit IgG antibodies against the murine homologue of
human BP180 NC16A into healthy mice induces
subepidermal blisters.9 Moreover, injection of IgG anti-
human BP180 antibodies induces subepidermal blisters
in BP180-knockout mice engineered to express human
BP180.10stigative Pathology.
.Although there is overwhelming evidence that binding
of anti-BP180 autoantibodies to BP180 initiates disease, such
antibody-antigen interaction appears insufﬁcient to induce
blisters in various BP animal models. Indeed, there is ev-
idence that BP pathogenesis requires activation of com-
plement and the presence of neutrophils and mast cells,
although the role of mast cells has been questioned by a recent
study.11e14 BP autoantibodies binding to hemidesmosomes
are assumed not to disrupt epidermal cell-connective tissue
interaction. However, contrary to this assumption, recent
studies indicate that cultured keratinocytes treated with IgG
BP-IgG Induces BP180 Internalizationfrom patients with BP (BP-IgG) exhibit a reduction in the
adhesive strength and a loss in BP180 expression.15,16
Moreover, we have demonstrated that the velocity of kerati-
nocytes is increased by BP-IgG treatment in vitro.17 These
ﬁndings raise the question as to how BP autoantibodies
inﬂuence keratinocyte adhesion and migration without
involvement of various inﬂammatory processes. Hence, in
this study, we examined the functions of BP-IgG by following
the fate of green ﬂuorescent protein (GFP)etagged full-
length BP180 (GFP-BP180) after BP-IgG treatment in live
804G epithelial cells, which are known to assemble bona ﬁde
hemidesmosomes,18 and normal human epidermal keratino-
cytes (NHEKs).
Materials and Methods
IgGs from Patients with BP
In accordance with Osaka City University Hospital (Osaka,
Japan) and Kurume University Hospital (Fukuoka, Japan)
bylaws, we obtained patient consent for experimental pro-
cedures to be performed in Osaka City University Hospital
and Kurume University Hospital from each participating
patient on his or her ﬁrst visit to the hospital. BP-IgGs were
puriﬁed from the serum samples of 20 patients with BP who
were diagnosed as having BP based on the presence of
typical clinical, histological, and immunopathological ﬁnd-
ings. Their enzyme-linked immunosorbent assay (ELISA)
index values for BP180 NC16A autoantibodies were >100,
whereas their ELISA index values for BP230 autoantibodies
did not exceed 6. ELISAs were performed using commercial
kits (MESACUP BP180 test and BP230 ELISA kit; MBL,
Nagoya, Japan). IgGs were afﬁnity puriﬁed from the
serum samples using HiTrap Protein G HP Columns (GE
Healthcare, Buckinghamshire, UK). The medical ethical
committee of Osaka City University approved all studies
performed in this study. The study was conducted according
to the principles of the Declaration of Helsinki.
Preparation of HiLyte Fluor 647eConjugated IgG and
IgG F(ab0)2 and IgG Fab Fragments
HiLyte Fluor 647econjugated BP-IgG and nonpathological
IgG were prepared using the HiLyte Fluor 647 Labeling
Kit-NH2 (Dojindo, Kumamoto, Japan), according to the
manufacturer’s protocol. BP-IgG F(ab0)2 and BP-IgG Fab
fragments were generated by pepsin and papain, respectively,
using commercial kits (Pierce, Rockford, IL), according to the
manufacturer’s protocols.
Antibodies and Immunoﬂuorescence Probes
The rabbit anti-GFP monoclonal antibody (mAb; A11122)
was obtained from Invitrogen (Carlsbad, CA). The horse-
radish peroxidaseeconjugated goat anti-rabbit IgG polyclonal
antibody (pAb) was purchased from KPL (Gaithersburg,The American Journal of Pathology - ajp.amjpathol.orgMD). The rat mAb GoH3, a blocking antibody directed
against the extracellular portion of human a6 integrin, was
obtained from eBioscience (San Diego, CA). The mouse
mAb 3E1 (MAB1964), a blocking antibody against human
b4 integrin, was purchased from Millipore (Billerica, MA).
The mouse anti-human b4 integrin mAb (555722) was
purchased from BD Biosciences (San Diego, CA). The
mouse anti-rat b4 integrin (ab29042) was purchased from
AbCam (Cambridge, UK). The methods for the production
and characterization of 5E, a human mAb against BP230,
mAb-233, a mouse mAb against the extracellular domain of
BP180, and J17, a rabbit pAb against the N-terminal domain
of BP180, were described elsewhere.19e22 The antibodies
610457 (BD Biosciences), 610500 (BD Biosciences), and
3238 (Cell Signaling Technology Inc., Beverly, MA)
recognize early endosomal antigen-1 (EEA-1), clathrin, and
caveolin-1, respectively. The Alexa Fluor (AF) 488e and
AF 597elabeled secondary antibodies were obtained from
Invitrogen. The mouse anti-EGFR pAb (ab2430) was
purchased from AbCam.
Cells and Culture Conditions
The 804G cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (Invitrogen), supplemented with 10% fetal
bovine serum (Invitrogen) and 50 U/mL penicillin and
50 mg/mL streptomycin at 37C, in a humidiﬁed atmosphere
containing 5% CO2. NHEKs from neonate (Invitrogen)
were cultured ﬁrst in HuMedia-KG2 (Kurabo, Osaka,
Japan). When used for experiments, NHEKs were cultured
in HuMedia-KG2 containing 1.8 mmol/L CaCl2 for 12 to
24 hours.
IgG Stimulation
To examine the function of BP-IgG in 804G cells and
NHEKs, BP-IgG and normal IgG were added at ﬁnal
concentrations of 2.0 mg/mL in the culture media. Final
concentrations of GoH3 and 3E1 were 30 mg/mL in the
culture media. Final concentrations of 1.47 mg/mL BP-IgG
F(ab0)2 and 1.33 mg/mL BP-IgG Fab fragments in the
culture media were used in certain studies.
Endocytosis Inhibitors
The 1 mmol/L N-ethylmaleimide (NEM; Sigma-Aldrich, St.
Louis, MO), 0.4 mol/L sucrose (Sigma-Aldrich), 50 mmol/L
nystatin (Sigma-Aldrich), 100 mmol/L genistein (Wako,
Osaka, Japan), 2 mmol/L cytochalasin D (Sigma-Aldrich),
and 200 mmol/L 5-(N-ethyl-N-isopropyl) amiloride (EIPA;
Sigma-Aldrich) were added in the culture media 30 minutes
before the experiments (except for nystatin with 1-hour
treatment). The effects of these inhibitors of general, cla-
thrin-dependent, and caveolae-dependent endocytosis were
conﬁrmed by preliminary experiments using 804G cells,
which were incubated with 1 mg/mL recombinant rat EGF829
Figure 1 GFP-BP180 incorporates into hemidesmosome-like structures
in 804G cells and NHEKs. A: GFP-BP180eexpressing 804G cells were stained
using antibody against rat b4 integrin or 5E antibody against BP230.
GFP-BP180 localized precisely with b4 integrin and BP230 in a cat
pawelike pattern at the substratum-attached surface. B: Immunoﬂuores-
cence analyses of GFP-BP180eexpressing NHEKs using GoH3 mAb against
human a6 integrin, antibody against human b4 integrin, or 5E antibody
against BP230. GFP-BP180 colocalized with other hemidesmosomal
components. Scale bars: 10 mm.
Hiroyasu et al(R&G Systems, Inc., Minneapolis, MN) for 1 hour to trigger
EGFR internalization, a typical clathrin-dependent endo-
cytic event, or with 3 mg/mL AF 594econjugated cholera
toxin subunit B (CTB; Invitrogen) for 30 minutes to trigger
internalization of CTB itself, a typical caveolae-dependent
endocytosis. EGFR was visualized by immunoﬂuores-
cence staining with anti-EGFR pAb, and AF 594econ-
jugated CTB was monitored directly by a TCS SP5 confocal
microscope (Leica Microsystems, Mannheim, Germany),
after treatment with the indicated inhibitors. Microscope
images were exported as .tif ﬁles, and ﬁgures were gener-
ated using Adobe Photoshop CS5 (Adobe Systems, San
Jose, CA).
Immunoﬂuorescence Analyses
The cells grown on glass coverslips were ﬁxed in 3.7%
formaldehyde in PBS for 8 minutes, washed thoroughly in
PBS, and permeabilized in 0.1% (v/v) Triton X-100 in PBS
for 10 minutes. Primary antibodies were overlaid onto the
cells, and the preparations were incubated at 37C for 1
hour. The cells on coverslips were washed with PBS, and
conjugated secondary antibodies were applied for 1 hour at
37C. After being washed with PBS, coverslips were
mounted onto slides. All preparations were examined by the
TCS SP5 confocal microscope.
Western Blot and SDS-PAGE Analyses
For Western blot analyses of whole-cell lysates, the cells
were lysed in RIPA Lysis buffer (Upstate, Lake Placid, NY)
and boiled in NuPAGE LDS sample buffer (Invitrogen)
containing 2.5% 2-mercaptoethanol (Wako). Each sample
was processed for SDS-PAGE in 3% to 8% NuPAGE Tris-
Acetate Mini Gels (Invitrogen). The separated proteins were
transferred to Hybond-P polyvinylidene diﬂuoride
membranes (GE Healthcare). These membranes were pro-
bed with anti-GFP antibody or J17, washed, and probed
with horseradish peroxidaseeconjugated goat anti-rabbit
pAb. Signals were detected with Super Signal West Dura
Substrate (Thermo Fisher Scientiﬁc, Rockford, IL).
Samples of F(ab0)2 and Fab fragments in LDS sample
buffer were processed for SDS-PAGE in 4% to 12% Nu-
PAGE Bis-Tris Mini Gels (Invitrogen) to conﬁrm the ab-
sence of the undigested IgG in the solutions. The membrane,
to which the proteins were transferred, was stained with
amido-black (Sigma-Aldrich).
Plasmid Constructs
mRNAs were extracted from subconﬂuent cultures of
NHEKs using the RNeasy Plus Mini Kit (Qiagen, Mis-
sissauga, ON, Canada), and cDNAs were generated using
the High Capacity cDNA reverse transcription kit (Applied
Biosystems, Foster City, CA). cDNAs encoding the 50 half
and 30 half of human BP180 were generated by PCR from830the cDNA library using the following primers: 50-CGC-
GGATCCATGGARGRAACCAAGAAAAACAA-30 (for-
ward) and 50-TTCACCTTTTATTCCTGGTCG-30 (reverse)
and 50-CCCAAGCTTCGGCTTGACAGCAATACT-30 (for-
ward) and 50-AGGAAAGCCAGGTCTCACAG-30 (re-
verse), respectively. After gel puriﬁcation and restriction
digestion with BamHI, KpnI, and NotI, both cDNA frag-
ments were ligated into the BamHI/NotI sites of Kikume
Green-Red, mammalian expression vector (MBL). The
construct was sequenced using the ABI3130xl sequencer
(Applied Biosystems) to ensure that it was in frame and had
no errors. After restriction digestion with NheI, NotI, and
DraI, the cDNA fragments were ligated into the NheI/NotIajp.amjpathol.org - The American Journal of Pathology
Figure 2 BP-IgGeinduced GFP-BP180 internalization in live 804G cells and NHEKs. Live cell imaging studies of subconﬂuent (A) and conﬂuent (C) cultures
of 804G cells and subconﬂuent (B) and conﬂuent (D) cultures of NHEKs. GFP-BP180eexpressing cells were visualized by confocal microscopy, either along
their substrate-attached surface (basal level) or at a higher focal plane (equatorial level), at various intervals after BP-IgG treatment. In both cell types and
conditions, GFP-BP180 was internalized and redistributed centripetally toward the perinuclear region (AeD). Z-sections of the cells are shown at the bottom of
each column. At the right, images of the cell border at time 0 and the end of the observation are shown in green and red, respectively. In 804G cells, rounding
up of the cells was observed (A and C). Scale bars: 10 mm.
BP-IgG Induces BP180 Internalization
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Figure 3 BP-IgG F(ab0)2 and BP-IgG Fab fragments induce GFP-BP180 internalization in live 804G cells. Live cell imaging studies of subconﬂuent cultures
of 804G cells treated with BP-IgG F(ab0)2 (A) and BP-IgG Fab (B) fragments. GFP-BP180 was internalized and redistributed centripetally toward the perinuclear
region after treatment with both fragments. The fragments induced some cell rounding, as indicated by the outlines of the treated cells at times 0 and 180
minutes, shown to the right. Scale bars: 10 mm.
Hiroyasu et alsite of pcDNA 3.1/NT-GFP-TOPO mammalian expression
vector (Invitrogen). A stop codon was inserted at the end of
the part of BP180 by a KOD mutagenesis kit (Toyobo,
Osaka, Japan) using a forward primer, 50-TGAAAGGGC-
GAATTCTGCAGATATCCATCACA-30, and a reverse
primer, 50-CGGCTTGACAGCAATACTTCTTCTCCTTC-
TC-30, and the ﬁnal clone was designated GFP-BP180.
GFP-BP180was sequenced again to ensure that it was in frame
and had no errors. A construct PmKate2-zyxin was purchased
from Evrogen (Moscow, Russia). A construct encoding GFP-
tagged b4 integrin was characterized elsewhere.23
Transfection Procedures
At 24 hours before transfection, the culture media for 804G
cells and NHEKs were changed to Dulbecco’s modiﬁed
Eagle’s medium and HuMedia without antibiotics, respec-
tively. Transfections were performed using the Lipofectamine
2000 reagent (Invitrogen) or polyethyleneimine (Sigma-
Aldrich) in OPTI-MEM (Gibco, Grand Island, NY) with the
vectors. Six hours later, the media were replaced with normal
media. At 24 hours after transfection, the cells were suspended
and seeded onto triple-well glass-bottomed dishes (Asahi
Techno Glass Co, Tokyo, Japan). At 24 hours after seeding,832804G cells were immediately processed for live cell imaging,
whereas NHEKs were further cultured in high Ca2þ medium
for 12 to 24 hours before imaging. For Western blot analyses,
GFP-positive NHEKs were sorted by using an FACS Vantage
SE sorter (BD Biosciences), whereas transfected 804G cells
were selected in 1000 mg/mL G418 (Sigma-Aldrich).
Live Cell Imaging
Time-lapse microscopy of the cells on triple-well glass-
bottomed dishes was performed with the confocal laser
scanning microscope, type TCS SP5. Subconﬂuent cultures
of the cells were scanned every 5 minutes, and conﬂuent
cultures were scanned every 15 or 30 minutes.
Fluid-Phase Uptake Assay
Subconﬂuent cultures ofGFP-BP180etransfected 804G cells
on glass-bottomed dishes were incubated with 2.0 mg/mL
BP-IgG and 0.5 mg/mL 10-kDa dextraneAF 594 (Invi-
trogen), a ﬂuid-phase marker, for 10 minutes. The cells were
ﬁxed in 3.7% formaldehyde in PBS for 8minutes. After being
washed with PBS, the cells were observed with the TCS SP5
confocal microscope.ajp.amjpathol.org - The American Journal of Pathology
Figure 4 BP-IgGeinduced GFP-BP180 internalization is mediated through endocytosis. A: After the incubation with BP-IgG for 1 hour, GFP-
BP180eexpressing 804G cells were stained for EEA-1, which showed some colocalization with GFP-BP180 in the cytoplasm (arrows). In contrast, after a 2-hour
incubation with BP-IgG, GFP failed to colocalize with either clathrin (B) or caveolin-1 (C). Scale bars: 5 mm.
BP-IgG Induces BP180 InternalizationDetachment of Colonies from the Bottom of the
Culture Plate
The strength of adhesion was measured as previously
detailed.15 Brieﬂy, NHEKs cultured for 50 hours were treated
with 2.0 mg/mL BP-IgG or normal IgG for 6 hours, followed
by pre-incubation with or without EIPA for 30 minutes. After
vortex mixing for 30 minutes, the numbers of attached cells
were counted.
Statistical Analysis
Data are expressed as means  SDs from three different
measurements for individual samples from ﬁve different
experiments. Statistical signiﬁcance was determined by the
Student’s t-test. P  0.01 was considered signiﬁcant.
Results
GFP-BP180 Expression in 804G Cells and NHEKs
without BP-IgG Treatment
In 804G cells, transfected GFP-BP180 codistributed with
other hemidesmosomal components, including b4 integrin
and BP230, in a cat pawelike pattern at the substratum-
attached surface of the cells (Figure 1A). In NHEKs,
transfected GFP-BP180 mainly localized at the substratum-The American Journal of Pathology - ajp.amjpathol.orgattached surface of the cells, where it colocalized with a6
integrin, b4 integrin, and BP230 (Figure 1B). Western blot
analyses of extracts from the GFP-BP180etransfected 804G
cells and NHEKs were performed to conﬁrm the appropriate
expression of GFP-BP180 protein. In transfected 804G
cells, anti-BP180 antibody recognized strongly endogenous
BP180 and weakly a 207-kDa polypeptide consistent with
recombinant BP180 fused with a 27-kDa GFP tag, whereas
anti-GFP mAb recognized only the 207-kDa recombinant
BP180 (Supplemental Figure S1A). In transfected NHEKs,
a similar expression pattern was found (Supplemental
Figure S1B).BP-IgG Treatment Induces an Internalization of
GFP-BP180
To observe the dynamics of BP-IgGebound BP180, we
followed GFP-BP180 in subconﬂuent cultures of 804G cells
by live cell imaging, after treatment with BP-IgG at
a concentration of 2.0 mg/mL (Figure 2A and Supplemental
Movie S1). Before BP-IgG treatment, GFP-BP180 localized
mainly at the substratum-attached surface of the cells in
a distinct patch-like pattern, whereas some GFP-BP180
localized diffusely in the cytoplasm. Approximately 10
minutes after BP-IgG treatment, GFP-BP180 was detected
in the cytoplasm as deﬁned spots. By 90 minutes,833
Hiroyasu et alGFP-BP180epositive cytoplasmic inclusions redistributed
centripetally toward the perinuclear region. Interestingly,
the patches of GFP-BP180 localized along the substratum-
attached surface of the cell maintained their form
throughout the observation period (up to 180 minutes). At
180 minutes after treatment with BP-IgG, the cells rounded
up (Figure 2A). However, the treated cells did not detach
from the dish during the observation period. There was
neither obvious GFP-BP180 dynamic movement nor
observable morphological changes in subconﬂuent cultures
of 804G cells treated with normal IgG during the same
time period (Supplemental Figure S2A).
In subconﬂuent cultures of NHEKs treated with BP-IgG,
GFP-BP180 was internalized from the substratum-attached
surface into the cytoplasm as spot-like structures within
approximately 20minutes (Figure 2B and SupplementalMovie
S2). Most of the internalized GFP-BP180 showed a centripetal
redistribution by 90 minutes. Compared with the results in
804G cells, less GFP-BP180 localized in the cytoplasm at 180
minutes afterBP-IgG treatment. The cells did not showobvious
rounding up at 180 minutes after BP-IgG treatment, in contrastFigure 5 Pre-incubation with the inhibitors of general endocytosis and macro
imaging studies for GFP-BP180eexpressing 804G cells (AeF) and NHEKs (G) tre
inhibited BP-IgGeinduced GFP-BP180 internalization and cell morphological chan
failed to prevent GFP-BP180 internalization in BP-IgGetreated 804G cells. Cytoch
G: In NHEKs, EIPA prevented BP-IgGeinduced GFP-BP180 internalization at 180
834to what was observed under the same conditions using 804G
cells (Figure 2B). Control IgG showed no particular effects on
GFP-BP180 expression and the morphological characteristics
in NHEKs (Supplemental Figure S2B).
GFP-BP180 expressed in NHEKs treated with inhibitory
antibodies against the hemidesmosome proteins a6 integrin
(GoH3) or b4 integrin (3E1) failed to become cytoplasmic,
although the treated cells changed shapes and partially
detached from their substrate (Supplemental Figure S2,
C and D). Moreover, in NHEKs expressing either GFP-
tagged b4 integrin or pmKate2-zyxin, a focal contact
component, there was no internalization of either tagged
protein after BP-IgG treatment (Supplemental Figure S2, E
and F). However, the amount of tagged zyxin was reduced
at 135 minutes after BP-IgG treatment.
Next, we followed the fate of GFP-BP180 for 6 hours in
conﬂuent cultures of 804G cells and NHEKs treated with
BP-IgG (Figure 2, C and D, and Supplemental Movies S3
and S4). GFP-BP180 was internalized, as was the case in
subconﬂuent cultures, although the time course and the
numbers of internalized dot-like structures were distinct.pinocytosis prevents BP-IgGeinduced GFP-BP180 internalization. Live cell
ated with BP-IgG and endocytosis inhibitors. A: Pre-incubation with NEM
ges in 804G cells. Hypertonic sucrose (B), nystatin (C), and genistein (D)
alasin D (E) and EIPA (F) inhibited GFP-BP180 internalization in 804G cells.
minutes. Scale bars:10 mm.
ajp.amjpathol.org - The American Journal of Pathology
BP-IgG Induces BP180 InternalizationGFP-BP180 was internalized in conﬂuent cultures of 804G
cells and NHEKs within 30 and 105 minutes, respectively,
after treatment with BP-IgG. Moreover, in both 804G cells
and NHEKs, a centripetal redistribution of GFP-BP180
was observed at 180 and 210 minutes, respectively. Com-
pared with our observations on subconﬂuent cultures, less
GFP-BP180 was internalized in conﬂuent cultures of both
cell types after BP-IgG treatment. As was the case in sub-
conﬂuent cultures, BP-IgGeinduced cell rounding of
NHEKs in conﬂuent cultures had a much less dramatic
effect than that of 804G cells in conﬂuent cultures (Figure 2,
C and D).
Treatments with BP-IgG F(ab0)2 and BP-IgG Fab
Fragments Induce an Internalization of GFP-BP180
The live cell imaging observations shown in Figure 2 sug-
gested that BP-IgG treatment induces BP180 internalization.
If it was mediated through a noninﬂammatory pathway, the
Fc portion of BP-IgG might not be required. Therefore, we
next examined whether GFP-BP180 is internalized after
treatments with BP-IgG F(ab0)2 and BP-IgG Fab fragments.
To generate F(ab0)2 and Fab fragments, BP-IgG was digestedFigure 6 Internalized BP180 colocalizes with the ﬂuid-phase marker. After i
BP180eexpressing 804G cells were ﬁxed and viewed. A: Boxed areas are shown a
with some GFP-BP180 as spot-like structures near the cell surface (arrows). Pre-in
of GFP-BP180 and dextran. Scale bars: 10 mm.
The American Journal of Pathology - ajp.amjpathol.orgby pepsin and papain, respectively. We conﬁrmed the
absence of undigested IgG and the high purity of F(ab0)2 and
Fab fragments by SDS-PAGE (Supplemental Figure S3).
Live cell imaging observations conﬁrmed that both F(ab0)2
and Fab fragments induced GFP-BP180 internalization in
subconﬂuent cultures of 804G cells (Figure 3, A and B). The
results suggested that BP-IgGeinduced BP180 internaliza-
tion is regulated by an FcR-independent mechanism. For
this and some following studies, we used only GFP-
BP180eexpressing 804G cells, because these cells showed
a more prominent internalized tagged protein.
BP-IgGeInduced BP180 Internalization Is Mediated
through a Clathrin-, Caveolae-, and Tyrosine
KinaseeIndependent Endocytic Pathway
To test whether BP180 internalization is mediated through
an endocytic pathway, we performed immunoﬂuorescence
analyses using representative molecules for the endocytic
pathway. We examined localization of EEA-1 at 1 hour after
BP-IgG treatment, and clathrin and caveolin-1 at 2 hours
after BP-IgG treatment. Approximately 15% of internalized
GFP-BP180 colocalized with EEA-1 (Figure 4A). Inncubation with BP-IgG and 10-kDa dextraneAF 594 for 10 minutes, GFP-
t a higher power; 10-kDa dextraneAF 594 was internalized and colocalized
cubation with cytochalasin D (B) and EIPA (C) inhibited the internalization
835
Hiroyasu et alcontrast, internalized GFP-BP180 did not colocalize with
either clathrin or caveolin-1 (Figure 4, B and C). These
results suggested that BP-IgGeinduced BP180 internaliza-
tion occurs via a clathrin- and caveolae-independent endo-
cytic pathway.
We next examined the effect of NEM, hypertonic sucrose,
nystatin, and genistein. We conﬁrmed the activity of these
inhibitors of general, clathrin-dependent, and caveolae-
dependent endocytosis in 804G cells by analyzing the
localization of EGFR, which undergoes clathrin-dependent
endocytosis, and CTB, which undergoes caveolae-dependent
endocytosis (Supplemental Figure S4).24
NEM dramatically inhibited both GFP-BP180 internali-
zation and the morphological changes in 804G cells induced
by BP-IgG treatment, suggesting that BP-IgGeinduced
BP180 internalization is mediated through an endocytic
pathway (Figure 5A). In contrast, pre-incubation with hy-
pertonic sucrose, a clathrin-dependent endocytosis inhibitor,
failed to prevent BP180 internalization (Figure 5B). Simi-
larly, nystatin (Figure 5C) and genistein (Figure 5D) did not
inhibit BP-IgGeinduced BP180 internalization. Because
nystatin is a caveolae-dependent endocytosis inhibitor and
genistein is a tyrosine kinase inhibitor, these results
conﬁrmed that BP180 endocytosis is mediated through
clathrin-, caveolae-, and tyrosine kinaseeindependent
mechanisms.
BP-IgG Induces BP180 Internalization via
a Macropinocytic Pathway
We next investigated whether BP-IgGeinduced BP180 inter-
nalization involved macropinocytosis. Macropinocytosis can
be distinguished by an involvement of actin dynamics and
Naþ/Hþ exchanger and non-speciﬁc ﬂuid uptake.25,26 In this
study, GFP-BP180eexpressing 804G cells were treated withFigure 7 BP-IgG treatment increases the detachment of NHEKs from their subs
EIPA. After pre-incubation with (B) or without (A) EIPA, NHEKs were treated with or
the numbers of adherent cells were counted. The y axis depicts the percentage of ad
calculated as 100%. A: Without pre-incubation with EIPA, the adhesive strength
normal IgG-treated cells. *PZ 0.38 (not signiﬁcant); **PZ 0.0017; ***PZ 0.006
BP-IgGetreated cells was comparable to normal IgG-treated and non-treated cells
836BP-IgG in the presence of either cytochalasin D (Figure 5E) or
EIPA (Figure 5F). These macropinocytosis inhibitors blocked
GFP-BP180 internalization in 804G cells. Moreover, in
NHEKs, GFP-BP180 internalization was inhibited by EIPA
(Figure 5G).We further conﬁrmed that someof the internalized
BP180 colocalized with 10-kDa dextraneAF 594 in 804G
cells (Figure 6A). The internalization of the ﬂuid-phasemarker
was inhibited by pre-incubation with cytochalasin D and EIPA
(Figure 6, B and C). These results demonstrated the partici-
pation of macropinocytosis in BP-IgGeinduced BP180
internalization.
Macropinocytosis Inhibitor Rescues BP-IgGeInduced
Reduction in the Adhesive Strength of the Cells
A previous study has shown that BP-IgG treatment reduces the
adhesive strength of the cells to their substrate.15 Hence, we
assessed whether EIPA inhibits this phenomenon. Non-treated,
normal IgGetreated, and BP-IgGetreatedNHEKswere vortex
mixed after pre-incubation with or without EIPA, and then the
numbers of adherent cells were counted. BP-IgG treatment
decreased the adhesive strength of the cells, which was
consistent with the result of the previous study.15 In contrast,
after pre-incubation with EIPA, BP-IgGetreated NHEKs did
not exhibit a reduction in the adhesive strength, compared with
normal IgG-treated or non-treated cells (Figure 7).
BP180 Is Internalized along with BP-IgG
We next examined whether BP-IgG is internalized along
with its antigen, BP180. For this purpose, 804G cells
expressing GFP-BP180 were incubated with HiLyte Fluor
647econjugated BP-IgG for 30 minutes, washed, and then
observed. HiLyte Fluor 647econjugated BP-IgG was clus-
tered along the cell substratumeattached surface, togethertrate after vortex mixing, and the effect is inhibited by pre-incubation with
without normal IgG and BP-IgG for 6 hours. The cells were vortex mixed, and
herent cells after agitation. The control index value without IgG addition was
of BP-IgGetreated cells was reduced to approximately 60% compared with
1. B: After pre-incubation with EIPA for 30 minutes, the adhesive strength of
. *PZ 0.96; **PZ 1.00; ***PZ 0.96 (no signiﬁcant differences).
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Figure 8 HiLyte Fluor 647econjugatedBP-IgG is internalized alongwithBP180.HiLyte Fluor 647econjugatedBP-IgG (A andB) andHiLyte Fluor647econjugated
normal IgG (C) were observed in GFP-BP180eexpressing 804G cells after incubation for 30 minutes. A: HiLyte Fluor 647econjugated BP-IgG colocalized with GFP-
BP180 into hemidesmosome-like structures at the cell substratumeattached surface. B: At the equatorial plane, internalized BP-IgG was visible and colocalized
with internalized GFP-BP180 (arrows). C: HiLyte Fluor 647econjugated normal IgG failed to induce internalization of both IgG and GFP-BP180. Scale bars: 10 mm.
BP-IgG Induces BP180 Internalizationwith GFP-BP180 (Figure 8A), and distributed as cyto-
plasmic spots (Figure 8B). Some of the internalized BP-IgG
spots colocalized with GFP-BP180. In contrast, after in-
cubation with HiLyte Fluor 647econjugated normal IgG,
neither GFP-BP180 nor normal IgG was internalized
(Figure 8C). These results suggested that a complex of BP-
IgG bound to its BP180 antigen is internalized.
Intracellular and Extracellular Domains of BP180 Are
Internalized Simultaneously
BP180 undergoes proteolytic cleavage during migration and
other pathological conditions.27e30 The precise cleavage sites
are unclear but may exist in the NC16A domain.27,29,30
To examine whether proteolytic cleavage of BP180 occurs
during BP-IgGeinduced internalization, BP-IgGetreated
GFP-BP180eexpressing 804G cells were stained with anti-
body mAb233, which recognizes the extracellular domain of
BP180. BP-IgGetreated untransfected NHEKs were doubly
stained with mAb233 and antibody J17, which recognizes the
cytoplasmic domain of BP180. These studies showed that
both intracellular and extracellular domains of internalized
BP180 colocalized as cytoplasmic spots in both cell types
(Figure 9, A and B).The American Journal of Pathology - ajp.amjpathol.orgDiscussion
The aim of the present study was to assess the role of BP-IgG
in the initiation of noninﬂammatory blister formation in BP in
an in vitro system. Our results indicate the following: i) BP-
IgG causes BP180 internalization and morphological
changes by an FcR-independent mechanism, which is
consistent with the results of the previous studies,15,16,31,32 ii)
BP-IgGeinduced BP180 internalization and BP-IgGe
induced reduction in the adhesive strength of the cells require
macropinocytosis, iii) BP180 is internalized, along with BP-
IgG, and iv) both intracellular and extracellular domains of
BP180 are internalized after binding with BP-IgG.
In subconﬂuent cultures of both 804G cells and NHEKs,
BP180 internalization induced by BP-IgG occurs rapidly,
within <30 minutes. Interestingly, there are some differ-
ences in the fates of BP180 and the morphological
characteristics between 804G cells and NHEKs. The 804G
cells showed more prominent GFP-BP180 internalization
and cell rounding than in NHEKs. This may reﬂect the
different amino acid sequences between rat BP180 and
human BP180, speciﬁcally in the binding site to a6 integ-
rin.33 This raises the possibility that, in 804G cells, GFP-
human BP180 may not be constrained at the plasma837
Figure 9 The intracellular domain of BP180 is internalized, along with the extracellular domain of BP180. A: GFP-BP180eexpressing 804G cells were
stained using anti-extracellular BP180 domain antibody mAb233, 2 hours after the incubation with BP-IgG. B: NHEKs were doubly stained using mAb233 and
anti-cytoplasmic BP180 domain antibody J17. These studies showed that both intracellular and extracellular domains of internalized GFP-BP180 colocalized as
cytoplasmic spots (arrows). Scale bars: 5 mm.
Hiroyasu et almembrane by a6 integrin, resulting in higher internalization
and less adhesion.
We conﬁrmed that BP-IgGeinduced BP180 internaliza-
tion also occurs in conﬂuent cultures, although the process
appears less efﬁcient than in subconﬂuent cultures. This
result is important, because conﬂuent cultures mimic more
the in vivo situation. Less efﬁcient internalization may
reﬂect lower accessibility of BP-IgG to the substratum-
attached surface of the cells in conﬂuent cultures.
Based on the results of our ﬂuid-uptake and live cell
imaging assays using cytochalasin D and EIPA, which
inhibit actin polymerization and transmembrane Naþ
transport systems, respectively, we conclude that BP180
internalization occurs via macropinocytosis. Moreover,
macropinocytosis of BP180 reduces cell-substrate adhesion,
because EIPA rescues BP-IgGeinduced detachment of the
cells after vortex mixing. Interestingly, we also showed that
a tyrosine kinase is unlikely to be involved in BP-IgGe
induced BP180 internalization. This is not contrary to the
literature because the role of tyrosine kinases in macro-
pinocytosis is controversial.25,34e36
Our results have an interesting parallel with those
involving the pathogenesis of another blistering skin dis-
ease, pemphigus vulgaris (PV). The PV antigen, desmo-
glein 3 (Dsg3), undergoes endocytosis after PV
autoantibody binding.24,37,38 Such as the BP180 internal-
ization shown herein, PV-IgGeinduced Dsg3 internaliza-
tion is mediated by a clathrin- and dynamin-independent
mechanism.24 However, in contrast to BP180 internaliza-
tion, both nystatin and genistein inhibit PV-IgGeinduced
Dsg3 internalization. Therefore, Dsg3 and BP180 inter-
nalizations are considered to be controlled by distinct
endocytic pathways. The difference in cytoplasmic838domains between Dsg3 and BP180 may specify the
distinct endocytic pathways by which these internaliza-
tions are regulated.24
Some reports have suggested that ectodomain shedding of
BP180 occurs in BP, although its pathogenic role is un-
clear.29,30,39e41 In this study, we detected both intracellular
and extracellular domains in the internalized BP180, sug-
gesting that ectodomain shedding of BP180 does not
necessarily occur in BP180 internalization and may not be
essential to BP disease onset.
Some previous studies have reported that BP-IgG F(ab0)
2 and BP-IgG Fab fragments are insufﬁcient to induce
blisters in mouse models of the disease.11,42,43 In contrast,
herein, we have shown that whole IgG and BP-IgG F(ab0)2
and BP-IgG Fab fragments cause BP180 internalization
and cell morphological changes. One possible explanation
for these contradictory results is that BP-IgGeinduced
BP180 internalization is insufﬁcient to induce blister
formation, although it reduces cell-extracellular matrix
adhesive strength. We speculate that blistering requires
various inﬂammatory responses at the cell-extracellular
matrix zone, where it is ﬁrst weakened by BP180 inter-
nalization, further leading to a BP-speciﬁc split at the
lamina lucida. In other words, we suspect that blister
formation in BP requires both BP-IgGeinduced BP180
internalization and FcR-independent and FcR-dependent
immune responses.
In conclusion, the results of the present study suggest
that BP180 internalization is an early event in disease
pathogenesis of BP and occurs via a macropinocytic
pathway. This new understanding of disease pathogenesis
should provide us with new approaches for the treatment
of BP.ajp.amjpathol.org - The American Journal of Pathology
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